Insights Ahead: PDS Biotechnology's Quarterly Earnings
PDS Biotechnology (NASDAQ:PDSB) will release its quarterly earnings report on Wednesday, 2025-05-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate PDS Biotechnology to report an earnings per share (EPS) of $-0.22.
The market awaits PDS Biotechnology's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Overview of Past Earnings
During the last quarter, the company reported an EPS beat by $0.07, leading to a 0.8% increase in the share price on the subsequent day.
Here's a look at PDS Biotechnology's past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.28 | -0.34 | -0.37 |
| EPS Actual | -0.21 | -0.29 | -0.23 | -0.30 |
| Price Change % | 1.0% | -11.0% | -1.0% | 1.0% |
PDS Biotechnology Share Price Analysis
Shares of PDS Biotechnology were trading at $1.29 as of May 12. Over the last 52-week period, shares are down 64.03%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for PDS Biotechnology visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
English